Amino acid transporters in neurological disorders and neuroprotective effects of cysteine derivatives
Neurochemistry International · 2024-07 · 177 · 105771
DOI: 10.1016/j.neuint.2024.105771 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurochemistry International, 2024-07. Verfasst von Santosh Kumar Adla und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, P.O. Box 1627, FI-70211, Kuopio, Finland. Electronic address: santosh.…. Hauptthemen laut MEDLINE: Neuroprotective Agents, Cysteine, Nervous System Diseases, Amino Acid Transport Systems. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
For most diseases and disorders occurring in the brain, the full causes behind them are yet unknown, but many show signs of dysfunction of amino acid transporters or abnormalities in amino acid metabolism. The blood-brain barrier (BBB) plays a key role in supporting the function of the central nervous system (CNS). Because of its unique structure, the BBB can maintain the optimal environment for CNS by controlling the passage of hydrophilic molecules from blood to the brain. Nutrients, such as amino acids, can cross the BBB via specific transporters. Many amino acids are essential for CNS function, and dysfunction of these amino acid transporters can lead to abnormalities in amino acid levels. This has been linked to causes behind certain genetic brain diseases, such as schizophrenia, autism spectrum disorder, and Huntington's disease (HD). One example of crucial amino acids is L-Cys, the rate-limiting factor in the biosynthesis of an important antioxidant, glutathione (GSH). Deficiency of L-Cys and GSH has been linked to oxidative stress and has been shown as a plausible cause behind certain CNS diseases, like schizophrenia and HD. This review presents the current status of potential L-Cys therapies and gives future directions that can be taken to improve amino acid transportation related to distinct CNS diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, P.O. Box 1627, FI-70211, Kuopio, Finland. Electronic address: santosh.adla@uef.fi.
- School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, P.O. Box 1627, FI-70211, Kuopio, Finland.
Zitieren
APA
Adla, S. K., Virtanen, H., Thongsodsaeng, T., & Huttunen, K. M. (2024). Amino acid transporters in neurological disorders and neuroprotective effects of cysteine derivatives. Neurochemistry International, 177, 105771. https://doi.org/10.1016/j.neuint.2024.105771
Vancouver
Adla SK, Virtanen H, Thongsodsaeng T, Huttunen KM. Amino acid transporters in neurological disorders and neuroprotective effects of cysteine derivatives. Neurochemistry International. 2024;177:105771. doi:10.1016/j.neuint.2024.105771
BibTeX
@article{Adla2024,
author = {Adla, Santosh Kumar and Virtanen, Heinileena and Thongsodsaeng, Thanavit and Huttunen, Kristiina M},
title = {Amino acid transporters in neurological disorders and neuroprotective effects of cysteine derivatives},
journal = {Neurochemistry International},
year = {2024},
volume = {177},
pages = {105771},
doi = {10.1016/j.neuint.2024.105771}
}
EUVIMED